Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Down 23.2% in November

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 4,300 shares, a decline of 23.2% from the November 15th total of 5,600 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 43.0 days.

Laboratorios Farmaceuticos Rovi Price Performance

Shares of LABFF remained flat at C$65.86 during mid-day trading on Monday. Laboratorios Farmaceuticos Rovi has a 12 month low of C$65.86 and a 12 month high of C$65.86. The company has a 50-day moving average price of C$83.19 and a 200-day moving average price of C$87.29.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.